Citadel Advisors’s NeuroSense Therapeutics NRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $282K | Buy |
+149,243
| New | +$282K | ﹤0.01% | 4682 |
|
|
2025
Q1 | – | Sell |
-253,997
| Closed | -$305K | – | 6635 |
|
|
2024
Q4 | $305K | Buy |
253,997
+219,717
| +641% | +$264K | ﹤0.01% | 4502 |
|
|
2024
Q3 | $43.5K | Buy |
+34,280
| New | +$43.5K | ﹤0.01% | 5154 |
|
|
2023
Q4 | – | Sell |
-11,702
| Closed | -$8.78K | – | 6416 |
|
|
2023
Q3 | $8.78K | Buy |
+11,702
| New | +$8.78K | ﹤0.01% | 5450 |
|
|
2022
Q1 | – | Sell |
-55,119
| Closed | -$135K | – | 6868 |
|
|
2021
Q4 | $135K | Buy |
+55,119
| New | +$135K | ﹤0.01% | 5732 |
|